Related Experiment Video
Updated: Mar 8, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma
J Delyon1,2,3, A Servy1,2, F Laugier1,2
1INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France.
Abstract:
The cyclic AMP (cAMP) signaling pathway is critical in melanocyte biology for regulating differentiation. It is downregulated by phosphodiesterase (PDE) enzymes, which degrade cAMP itself. In melanoma evidence suggests that inhibition of the cAMP pathway by PDE type 4 (PDE4) favors tumor progression. For example, in melanomas harboring RAS mutations, the overexpression of PDE4 is crucial for MAPK pathway activation and proliferation induced by oncogenic RAS. Here we showed that PDE4D is overexpressed in BRAF-mutated melanoma cell lines, constitutively disrupting the cAMP pathway activation. PDE4D promoted melanoma invasion by interacting with focal adhesion kinase (FAK) through the scaffolding protein RACK1. Inhibition of PDE4 activity or inhibition of PDE4D interaction with FAK reduced invasion. PDE4D expression is increased in patients with advanced melanoma and PDE4D-FAK interaction is detectable in situ in metastatic melanoma. Our study establishes the role of PDE4D in BRAF-mutated melanoma as regulator of cell invasion, and suggests its potential as a target for preventing metastatic dissemination.
Insights
Phosphodiesterase type 4D (PDE4D) promotes melanoma invasion by disrupting cyclic AMP (cAMP) signaling and interacting with focal adhesion kinase (FAK). Inhibiting PDE4D or its interaction with FAK reduces invasion, suggesting PDE4D as a therapeutic target for melanoma metastasis.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- The cyclic AMP (cAMP) signaling pathway regulates melanocyte differentiation.
- Phosphodiesterase (PDE) enzymes, particularly PDE type 4 (PDE4), degrade cAMP and are implicated in melanoma progression.
- PDE4 overexpression is linked to MAPK pathway activation in RAS-mutated melanomas.
Purpose of the Study:
- To investigate the role of PDE4D in BRAF-mutated melanoma.
- To determine the mechanism by which PDE4D influences melanoma invasion.
- To evaluate PDE4D as a potential therapeutic target for melanoma metastasis.
Main Methods:
- Analysis of PDE4D expression in BRAF-mutated melanoma cell lines.
- Investigation of PDE4D interaction with focal adhesion kinase (FAK) via RACK1.
- Assessment of the effect of PDE4 inhibition and PDE4D-FAK interaction disruption on melanoma invasion.
- Evaluation of PDE4D expression and PDE4D-FAK interaction in patient samples.
Main Results:
- PDE4D is overexpressed in BRAF-mutated melanoma cell lines, constitutively disrupting cAMP signaling.
- PDE4D promotes melanoma invasion through interaction with FAK, mediated by RACK1.
- Inhibition of PDE4 activity or PDE4D-FAK interaction significantly reduced melanoma invasion.
- Increased PDE4D expression and detectable PDE4D-FAK interaction were observed in advanced and metastatic melanoma patients.
Conclusions:
- PDE4D acts as a key regulator of cell invasion in BRAF-mutated melanoma.
- The PDE4D-FAK interaction is crucial for melanoma cell invasion.
- PDE4D represents a promising therapeutic target for preventing melanoma metastasis.
Related Concept Videos
Cancer Cell Migration through Invadopodia
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Intracellular Signaling Affects Focal Adhesions
Some...
PI3K/mTOR/AKT Signaling Pathway
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

